Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,268
Ph III recruiting: 131
Growth YoY: +6.7%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,373)

clinicaltrialsPublishedShowing 101–150 of 1,636 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04673617	AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma	completed	Phase 1 / Phase 2	45	Artiva Biotherapeutics, Inc.INDUSTRY	1	Apr 3, 2026	clinicaltrials
NCT06492304	A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies	completed	Phase 1 / Phase 2	12	CRISPR TherapeuticsINDUSTRY	2	Apr 3, 2026	clinicaltrials